Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia

Summary

This is a phase II randomized, double-blind, placebo-controlled study where eligible subfertile male subjects (age 20 years).

Timeline

Start

2009-12

Primary completion

2012-12

Completion

2013-06

Outcome

Outcome not reported

Stopped: “no safety issues”

Drugs

Indications